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Abstract: Vitamin D receptor (VDR) mediates many genomic and non-genomic effects of vitamin D.
Recently, the mitochondrial effects of vitamin D have been characterized in many cell types. In this
article, we investigated the importance of VDR not only in mitochondrial activity and integrity but
also in cell health. The silencing of the receptor in different healthy, non-transformed, and cancer
cells initially decreased cell growth and modulated the cell cycle. We demonstrated that, in silenced
cells, the increased respiratory activity was associated with elevated reactive oxygen species (ROS)
production. In the long run, the absence of the receptor caused impairment of mitochondrial integrity
and, finally, cell death. Our data reveal that VDR plays a central role in protecting cells from excessive
respiration and production of ROS that leads to cell damage. Because we confirmed our observations
in different models of both normal and cancer cells, we conclude that VDR is essential for the health
of human tissues.
Keywords: vitamin D receptor; silencing; mitochondria; reactive oxygen species; respiratory chain;
cytochrome C; cell proliferation; cell death
1. Introduction
The active form of vitamin D (1,25(OH)2D3) exerts its beneficial effects on the whole organism by
regulating calcium homeostasis and by modulating a large set of genes involved in the differentiation
and function of virtually every tissue. The transcriptional control is mediated by the vitamin D
receptor (VDR), which promotes ligand-dependent induction or repression of gene transcription
together with its binding partner retinoid X receptor (RXR) and many recruited activators or repressors.
The incredibly high number of target genes accounts for the pleiotropic functions of VDR.
Besides the long-recognized role of 1,25(OH)2D3 in regulating calcium and phosphate metabolism,
many biological networks are influenced by VDR, including bone remodeling [1], xenobiotic
detoxification [2], cell physiology (reviewed in [3,4]), immunity [5], and metabolism [6–8]. Recently,
a novel mitochondrial localization of VDR has been described [9,10], and the characterized
mitochondrial function of 1,25(OH)2D3/VDR has been depicted as the hub linking the control of cell
metabolism to the transcriptional status of the cell. In fact, the work of our group [11,12] and others [13]
has demonstrated that, through VDR activity, 1,25(OH)2D3 reduces mitochondrial respiration and
rewires cell metabolism toward the biosynthetic pathways. This metabolic control sustains both the
proliferative asset [11] and more specialized functions of the cells [12], depending on the cellular
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phenotype. On the basis of these recent observations, it is clear that not only the defective activity of
VDR affects the expression of many genes, and thus the levels of many proteins, but also mitochondrial
metabolism and function must be profoundly altered by VDR failure. The mitochondrial compartment
is central in many processes; besides being the powerhouse of the cell, mitochondria are also important
reservoirs of metabolic intermediates, are considered calcium and iron stores [14,15], and behave as
molecular factories (for example they are the site of iron insertion in organic molecules). Given their
central role, a severe mitochondrial damage leads to apoptotic cell death.
The aim of this work was to explore the results of a defective expression of VDR in cell health
and function. We silenced the receptor in different cell types and observed a severe reduction in cell
proliferation followed by cell death. We investigated the molecular mechanisms governing the increased
vulnerability of the silenced cells and demonstrated the involvement of the mitochondrial compartment.
2. Results
2.1. Two Different Human Cell Lines and Human Primary Cells Silenced for VDR Strongly Reduce Their
Proliferation Rate
With the aim of investigating the effects of a severe reduction of VDR activity on cell physiology,
we silenced the receptor by lentiviral delivery of shRNA against human VDR. Three different cell types
were selected as examples of malignant, non-malignant, and healthy phenotypes: the human breast
cancer cell line MCF7, the human proliferating keratinocyte cell line HaCaT, and primary healthy
human fibroblasts, respectively. The genetic ablation of VDR expression by this technique was very
effective, as previously demonstrated [11], and the suppression of the protein was confirmed in all cell
types by western blotting analysis. The abatement of VDR expression is shown in Figure 1. One week
after infection, cell proliferation was investigated either by crystal violet staining (MCF7 and HaCaT
cells) or by BrdU incorporation (fibroblasts), and the results are presented in Figure 2A,B. In all cell
types, the silencing of VDR caused a great reduction of growth. Accordingly, the analysis of their cell
cycle showed a remarkably reduced S phase and a decreased G0/G1 phase, and the cells accumulated
in the G2/M phase (Figure 2C).
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Figure 1. shRNA-mediated Vitamin D receptor (VDR) knockdown in the human cells MCF7, HaCaT, 
and primary fibroblasts (Fb) abrogates VDR expression. The cells were silenced by lentiviral 
infection with an shRNA against VDR (shVDR) or with a scrambled non-targeting shRNA as control 
(shCTRL). Seven days after infection, VDR expression was evaluated in the cellular whole extracts by 
western blot analysis. Actin was detected as an internal control for protein loading. 
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primary fibroblasts (Fb) abrogates VDR expression. The cells were silenc d by lentiviral infection
with an shRNA against VDR (shVDR) or with a sc ambled non-targeting shRNA as control (shCTRL).
Seven days aft r infection, VDR expression was evaluated in the cellular whole extracts by western
blot analysis. Actin was detected as an intern l cont ol for protein loading.
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cycle was expressed as percentage of the shCTRL c lls in the same phase. The data are expressed as t
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2.2. The Ablation of VDR Enhances Mitochondrial Respiratory Activity and the Production of Reactive
Oxygen Species
We have previously demonstrated that VDR controls mitochondrial respiratory activity [11].
Here, we confirmed that VDR ilencing enhanced the respiratory activity of HaCaT cells by
m asuring the incr ment of mitochondrial membrane potential (Figure 3A); moreover, by real-time
PCR analysis of MCF7 and HaCaT transcripts, we detected the increased expression of several
compo ent of the respiratory chain coupled to oxidativ phosphorylation. Becau e both nucl ar-
and mitochondrial-encoded proteins are required for the formation of active respiratory complexes,
we evaluated the trans ription of two subunits of cytochrome C oxidase (COX or respiratory compl x
IV) and two subunits of ATP sy thase hose transcripts are both of mit chondrial and nucl ar origin:
COX2 and MT-ATP6 (a mitochondrial gene encoding th ATP synthase Fo subunit 6) are ma kers of
mitochondrial transcription activity, and COX4 and ATP5B (a nuclear gene encoding ATP synthase
subunit b ta) are markers of the nuclear c tribution to respiratory chain modulation. Their increased
expre sion, shown i Figure 3B, was in agreeme t with the observed enhanced respiratory membrane
pot nt al. One of the consequences of the spiratory burst is th production of reactiv oxyg n
spec es (ROS); the efore, we measur d ROS production in control cells and VDR knockdown ells.
We demonstrated the increase of ROS levels in all silenc cells (Figure 3C) a d detected the highest
increment i primary fibrobla s.
On the basis of our observations, we concluded that, in all cell types analyzed, VDR was
an essential negative modulator of mitochondrial respiratio , and its ablation increased both the
xpression and th activity of the respiratory ch in, and the consequent ROS produ tion.
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element of the respiratory chain is considered the hallmark of apoptosis driven by a defective 
mitochondrial function. We also investigated another marker of an ongoing apoptotic death: the 
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Figure 3. The silencing of VDR induces mitochondrial respiration and enhances the production of ROS.
The metabolic assays and the extraction of mRNA were carried out one week after silencing the cells
with shRNA control (shCTRL) or VDR shRNA (shVDR). (A) The mitochondrial respiratory activity
was assessed in HaCaT cells by cytofluorimetric evaluation of the mitochondrial dye JC-1, and (B) the
expression of the respiratory chain complexes was analyzed by real-time PCR. The values plotted on
the graph represent the fold change in transcript expression in silenced versus control cells and are
displayed as the means ± SD of three independent experiments; (C) reactive oxygen species (ROS)
production was measured and expressed relative to control cells. The data represent the means ± SD
of three independent experiments; * p < 0.05 compared to the control.
2.3. The Silencing of VDR Triggers Long-Term Cellular Damage and Cell Death
Two weeks after delivery of shRNA particles, the silenced cells lost their healthy phenotype
and looked damaged when observed under the microscope. We hypothesized a massive apoptotic
death caused by the measured increase of ROS; therefore, we decided to quantify the cellular damage
and to verify the mitochondrial origin of the death process. First, we assessed the release of the
enzyme lactate dehydrogenase (LDH) as a marker of lost cell integrity. The results of our analysis
are displayed in Figure 4A. As expected, all the silenced cells accumulated great amounts of LDH
in their supernatants in comparison to control cells. This increase in LDH was particularly evident
in the medium of the silenced fibroblasts. Next, we evaluated the signs of the lost mitochondrial
integrity by western blotting analysis of cytochrome C content in subcellular fractions. Total lysates
were prepared along with mitochondrial and cytosolic extracts, and the levels of cytochrome C were
quantified with a specific antibody. The results of our analysis are displayed in Figure 4B, and the data
were quantified and plotted in Figure 4C. Both in MCF7 and in HaCaT cells, we found a decreased
content of cytochrome C in the mitochondrial compartment and, alongside this loss, we detected the
increase of the mitochondrial protein in the cytosolic fractions. At the same time, the expression of
cytochrome C in the whole lysates was unchanged, demonstrating the release of the mitochondrial
protein pool into the cytosolic milieu. The intracellular trafficking of an essential element of the
respiratory chain is considered the hallmark of apoptosis driven by a defective mitochondrial function.
We also investigated another marker of an ongoing apoptotic death: the cleavage of the nuclear enzyme
poly ADP ribose polymerase (PARP). In fact, the proteolytic cleavage of PARP into 89 and 24 kDa
fragments by caspases is an early indicator of apoptosis [16]. We analyzed the protein content of
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nuclear preparations from control and silenced MCF7 and HaCaT cells and were able to detect a
decreased amount of the 116 kDa PARP protein in the nuclear extracts of silenced cells, which was the
demonstration of the occurring cleavage and loss of the full-length enzyme (Figure 4D). The results of
these experiments were quantified and plotted on graph, as shown in Figure 4E.
All together, our data demonstrated that the silencing of VDR led to a severe cell damage that
had all the signs of a mitochondrial-mediated apoptotic death.
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and a t tic death. Two weeks after sile cing, cell damage w s evaluated. (A) Toxicity was assayed
by lactate dehydrogenase (L H) release in the extracellular medium; (B) The intracellular levels of
cytochrome C were evaluated by western blotting analysis of total extracts (TOT), mitochondrial (MIT),
and cytosolic fractions. Actin expression was used as a control of equal loading in total and cytosolic
extracts, whereas equal mitochondrial loading was verified by VDAC detection; (C) Bands from three
different experiments were quantified and normalized for loading, and the data were plotted on graph
as percentage of control; (D) Full-length PARP (116 kDa) was detected in nuclear extracts of control
(shCTRL) or silenced cells (shVDR) by western blotting analysis, and PCNA was used as a loading
control. The blots are representative of three in ependent experiments; (E) The bands were quantified
and normalized for lo ding, a d the d ta were plott d on graph as centage of shCTRL. The data
represent the means ± SD of three independent experiments; * p < 0.05 compared to the control.
3. Discussion
Vitamin D is active in every tissue, and the perturbation of its signaling is involved in many
diseases [17]. The importance and the pleiotropic effects of the activity of its receptor VDR have been
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elucidated by the murine knockout models, which have displayed a modified phenotype in many
tissues, such as bone, intestine (reviewed in [18]), skin [19], lung [20], muscle [21], endothelium [22],
and adipose tissue, and in metabolism [23,24]. Although the knockout models are useful to investigate
the general pathways controlled by vitamin D, at the cellular level they have a major flaw: they
originate cells that, since their formation and embryonic development, have never relied on VDR
for transcriptional control and modulation of metabolism. If we wonder about the importance of
VDR activity and whether it is essential for cellular tasks, another approach is to knockdown the
receptor in a cell population that expresses VDR to modulate growth, differentiation, and many
other functions. When the deranged signaling of 1,25(OH)2D3 is investigated, it must be considered
that the insufficiency of vitamin D and the loss of the receptor have some similar but partly distinct
consequences. The hypocalcemic phenotype shared by vitamin D deficiency and VDR knockout models
can be reversed by a high-calcium diet [25], but even at very low levels of 1,25(OH)2D3, the VDR
can still operate in a ligand-independent modality [26,27] or can respond to other molecules [28–30].
Therefore, in order to analyze fully and unambiguously the perturbation of 1,25(OH)2D3 signaling,
the best approach is to delete the receptor, and we followed this line of investigation.
In this work, we carried out a genetic silencing of VDR in three cell types different from each
other, for the purpose of testing the general importance of VDR in cell physiology. MCF7 were selected
as an example of malignant human cancer cell lines, HaCaT cells were a good model of proliferating
but not transformed human keratinocytes, and primary human fibroblasts were chosen as a model of
healthy human cells.
The first important finding of this work was that the ablation of the receptor resulted in increased
respiratory activity that enhanced the production of intracellular ROS. Interestingly, in all cell types,
we found that VDR controls both the mitochondrial (COX2 and MT-ATP6) and the nuclear transcription
(COX4 and ATP5B) of the proteins involved in respiratory activity and ATP synthesis, in agreement
with the necessity of coordinating the nuclear and the mitochondrial transcription of the components
of the respiratory process. It is known that the respiratory chain is a major source of ROS; in particular,
the complexes I, III, and IV are involved in radical biosynthesis [31,32]. ROS production is beneficial to
some extent and is involved in cell cycle progression [33], but an excessive boost can be detrimental
and can trigger cell damage. In all three silenced cellular models, the increase in ROS levels was
remarkable, especially in primary fibroblasts, and could exceed the antioxidant defenses. Indeed,
while the initial effect of silencing was growth arrest and the modulation of the cell cycle, the long-term
effect of VDR loss was cell damage, measured as LDH release. The increase of ROS levels and the
toxicity were directly proportional, since we observed the smallest rise of ROS and toxicity in silenced
MCF7 and the highest effects in silenced primary fibroblasts. This observation is reasonably accounted
for by some reported characteristics of cancer cells. In fact, it is known that the transformed cells
use ROS signals to drive proliferation and other events required for tumor progression and that the
elevated ROS levels are balanced by an increased activity of antioxidant enzymes in cancer cells [34];
accordingly, the protective role of VDR was particularly evident in healthy fibroblasts, although, in our
experimental setting, VDR defended even the most transformed MCF7 cells against oxidative stress.
In our previous work, we demonstrated the metabolic importance of VDR and its effect on
proliferation: the receptor curbs the respiratory activity and allows the rewiring of metabolic
intermediates toward biosynthesis, thus sustaining proliferation [11]. The results of the present
research unveil a novel role for VDR in cellular physiology, namely, the protection from the excessive
respiratory activity and the limitation of ROS production. In this study, we observed the negative effects
of the derangement of the metabolic control exerted by VDR; indeed, in the long run, the excessive
production of ROS consequent to VDR ablation had deleterious effects on the mitochondrial function
and survival of cells. One of the consequences of the excessive damage caused by ROS is the variation
in mitochondrial membrane permeability that results in cytochrome C release and apoptotic death [35].
In line with this, we demonstrated that, after two weeks of absence of VDR, mitochondrial integrity
was lost, and the cells showed the signs of an apoptotic fate. The interplay between vitamin D–VDR,
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ROS signaling, and the antioxidant system is complex; on the one hand, it has been demonstrated
that vitamin D and its analogues can increase the cytotoxicity mediated by ROS [36], while, on the
other hand, few reports have proved that vitamin D–VDR is able to inhibit the apoptosis triggered
by oxidative stress [37–41]; in addition, in this study, for the first time, we showed the protective
role exerted by VDR itself, without additional stressors. Moreover, our study investigated a novel
mechanism involved in the antiapoptotic effects of VDR, previously ascribed only to its transcriptional
activity [42]. In fact, not only the loss of VDR disrupts the traditional pathways regulated by its
transcriptional control [42], but also, as we demonstrated, the silencing of VDR generates an unbalanced
metabolism that leads to cytotoxicity. Although we have displayed the essential role of VDR in cell
metabolism, health, and survival, our data and conclusions are not necessarily in contrast with the
fact that the VDR knockout phenotype in animals is not lethal. Obviously, the tissues lacking VDR
since their embryonic development have found compensatory mechanisms to balance the effects of
VDR deletion.
In conclusion, in the present study, we discovered a novel important role for VDR in cell health.
We demonstrated that the mitochondrial effects of the receptor not only regulate the respiratory
activity but also protect from oxidative damage and preserve mitochondrial integrity and cell survival.
Our data were obtained in different cell types, cancerous as well as healthy cells, rendering the
discovered novel function a general feature of vitamin D–VDR role in many tissues.
Another intriguing consideration about this study is based on the fact that the phenotype obtained
by the experimental silencing of the receptor could mimic the pathological situations in which the
expression of VDR is downregulated (for example by epigenetic mechanisms [43,44]) or its activity
is compromised (for example by polymorphisms [45,46]). It is interesting to highlight that many
respiratory chain dysfunctions and deleterious ROS overproduction are recurrent themes in human
pathologies, ranging from neurodegenerative diseases to cancer [47,48], and may be of paramount
importance in ageing [49]. The results of this study demonstrate the protective role of VDR and raise
the possibility that the loss of VDR function could be partly responsible of, or at least could be an
adverse event in such diseases.
4. Materials and Methods
4.1. Cell Culture
The immortalized human epidermal keratinocyte cell line (HaCaT) and the MCF7 human breast
cancer cell line were purchased from American Type Culture Collection (ATCC) (Manassas, VA, USA).
Dermal primary fibroblasts from healthy donors were obtained from Banca della Cute, Turin, Italy,
and were used in early passages. The cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) that had been supplemented with 10% fetal bovine serum and 1% antibiotics (penicillin,
streptomycin), at 37 ◦C in a humidified atmosphere containing 5% CO2. All culture reagents were
from Sigma-Aldrich (Sigma, St. Louis, MO, USA).
4.2. Lentiviral-Mediated shRNA Targeting
PLKO.1 lentiviral shRNA clones targeting the human VDR (TRCN0000276543) and a scrambled
nontargeting control were purchased from Sigma (Sigma Mission shRNA) (Sigma, St. Louis, MO, USA)
and were previously described and characterized in terms of efficiency [11]. Lentiviral transduction
particles were produced in HEK293T cells as previously reported [11]. Briefly, the cotransfection of the
shRNA plasmid together with the packaging vectors was carried out by lipofectamine reagent, and the
supernatants were used for overnight transduction of the cells. Puromycin selection began 24 h after
infection. Within one week from infection or after two weeks, the cells were seeded for experimental
assays or harvested for RNA and protein analysis.
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4.3. Extract Preparation and Western Blotting Analysis
Subcellular fractionation and Western blotting analyses were conducted as previously described [10].
The protein content of the total extracts and mitochondrial fractions was quantified using the DC
protein assay (Bio-Rad, Hercules, CA, USA); 50 µg of total lysates and 30 µg of the mitochondrial or
nuclear fractions were separated by 10% SDS-PAGE and analyzed using Western blotting. The analysis
of cytochrome C was carried out after a 12% SDS-PAGE. The proteins were immunostained with the
indicated primary antibodies for 1 h at room temperature, and detection of the proteins of interest was
performed using peroxidase-conjugated secondary antibodies (Pierce, Rockford, IL, USA), followed by
ECL detection (ECL detection kit, Perkin Elmer Life Science, Foster City, CA USA). Mouse anti-VDR
(sc-13133), anti-actin (sc-8432), anti-PCNA (sc-56), and rabbit anti-PARP (sc-7150) antibodies were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The anti-VDAC (anti-porin 31HL)
monoclonal antibody was purchased from Calbiochem (La Jolla, CA, USA). The mouse anti-cytochrome
C (65981A) antibody was from BD Biosciences Pharmingen (San Diego, CA, USA).
4.4. Real-Time Polymerase Chain Reaction (qRT-PCR)
Total RNA was extracted with TRIzol® (Invitrogen, Thermo Fisher Scientific, Waltham, MA,
USA). One µg of total RNA was reversely transcribed into cDNA, in a final volume of 20 µL, using
the High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific, Waltham, MA, USA),
according to the manufacturer’s instructions. Quantitative PCR was carried out in a final volume of
20 µL, using the SensiFASTTM SYBR® Hi-ROX Kit (Bioline Srl, Trento, Italy) with the following primers:
COX2, fwd 5′-CGACTACGGCGGACTAATCT-3′, rev 5′-TCGATTGTCAACGTCAAGGA-3′;
COX4, fwd 5′-CGAGCAATTTCCACCTCTGT-3′, rev 5′-GGTCAGCCGATCCATATAA-3′;
ATP5B, fwd 5′-GTGGGCTATCAGCCTACCCT-3′, rev 5′-CAAGTCATCAGCAGGCACAT-3′;
MT-ATP6, fwd 5′-CCAATAGCCCTGGCCGTAC-3′, rev 5′-CGCTTCCAATTAGGTGCATGA-3′; β2M,
fwd 5′-AGCAAGGACTGGTCTTTCTATCTC-3′, rev 5′-ATGTCTCGATCCCACTTAACTA-3′. Beta
2-microglobulin β2M was used as an internal control. PCR amplification was one cycle of denaturation
at 95 ◦C for 2 min, 40 cycles of amplification, including denaturation at 95 ◦C for 5 s and annealing/
extension at 60 ◦C for 30 s. The 2−∆∆Ct method was used to analyze the data.
4.5. Proliferation Assay
Within one week from silencing, the effect of VDR silencing on the growth of the different
human cells was determined either by colorimetric measurement of cell numbers by crystal violet
staining (MCF7 and HaCaT cells) or by BrdU incorporation (primary fibroblasts). The primary human
fibroblasts were poorly stained by the crystal violet method, and the detection by spectrophotometer
was inadequate to quantify these cells; therefore, the more sensitive BrdU assay was chosen. The same
number of control or silenced cells (2000, 1000, or 500 cells per well) was seeded on 96-multiwell plates,
and the cells were either cultured for five days and then stained with crystal violet or assayed after
two days for BrdU incorporation. At the end of this period, MCF7 and HaCaT cells were fixed for
15 min with 11% glutaraldehyde, and the plates were washed three times, air dried, and stained for
20 min with a 0.1% crystal violet solution. The plates were then extensively washed and air-dried prior
to solubilization of the bound dye with a 10% acetic acid solution. The absorbance was determined at
595 nm. The proliferation of primary fibroblasts was evaluated by the Cell Proliferation ELISA BrdU
kit (Roche Applied Science, Penzberg, Germany), used according to the supplied instructions. The data
collected from twelve wells were averaged for each experimental condition, and each experiment was
repeated three times.
4.6. Cell Cycle Analysis
Within one week from silencing, the control and silenced cells were seeded at the same density
and, after 48 h, were detached in 1 mL PBS-EDTA 5 mM by scraping, collected, and fixed in 70% cold
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ethanol. After 3 h at −30 ◦C, the cells were centrifuged at 2000 rpm for 5 min, washed twice with
PBS, resuspended in 200 µL MUSE® cell cycle reagent, and then incubated for 30 min in the dark at
room temperature. Cellular DNA content was analyzed by Muse Cell Analyzer (Merck S.p.a., Milan,
Italy). To quantify the relative percentage of cells in the G0/G1, S, and G2/M phases of the cell cycle,
the Muse™ Cell Analyzer software was used.
4.7. Cytofluorimetric Evaluation of the Mitochondrial Membrane Potential
JC-1, a mitochondrial dye that stains the mitochondria in living cells in a membrane
potential-dependent fashion, was used as previously reported [11]. Within one week from silencing,
HaCaT cells were harvested by trypsinization, washed with PBS, and incubated with JC-1 (2 mg/mL
final concentration) at 37 ◦C for 30 min. After washing, JC-1 accumulation was determined using flow
cytometric analysis. The amount of JC-1 retained by 10,000 cells per sample was measured at 530 nm
(FL-1 green fluorescence) and 590 nm (FL-2 red fluorescence) using a flow cytometer and analyzed
using Cell Quest Alias software. The ratio FL2/FL1 was evaluated to determine the mitochondrial
membrane potential.
4.8. Measurement of Intracellular ROS Production
After one week from silencing, the cells were harvested and loaded for 15 min with 10 µM
2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA, Sigma). DCFH-DA is a cell-permeable probe
that is cleaved intracellularly by nonspecific esterases to form DCFH, which is further oxidized by ROS
to form the fluorescent compound dichlorofluorescein (DCF) [50]. DCF fluorescence was determined
at an excitation wavelength of 504 nm and an emission wavelength of 529 nm, using a Packard EL340
microplate reader (Bio-Tek Instruments, Winooski, VT, USA). The fluorescence values were normalized
to the protein content and expressed as values relative to the control.
4.9. Toxicity Assay (LDH Release)
Two weeks after silencing, cell damage was evaluated by measuring the release of lactate
dehydrogenase in the growth medium. The medium was collected, and the cells were harvested by
scraping and sonicated on ice with two 10 s bursts. Protein content was quantified by the DC protein
assay. Aliquots of growth medium were supplemented with a reaction mixture for the measurement of
LDH, as previously described [51]. The enzymatic activity in the extracellular medium was measured
spectrophotometrically as absorbance variation at 340 nm (37 ◦C) and was expressed as µmol NADH
oxidized/min/mg cell protein, to normalize the extracellular activity to the cell number. The data
were plotted relative to control values.
4.10. Bands Quantification and Statistical Analysis
The bBands from protein electrophoresis were quantified by scanning digital densitometry using
an ImageJ software analysis (ImageJ version 1.29, Sun Microsystems Inc., Palo Alto, CA, USA). All data
were expressed as mean ± S.D of three independent experiments. Statistical analysis of the data was
performed using an unpaired, two-tailed Student’s t-test; p < 0.05 was considered to be significant.
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